NCT06312891

Value of Heart Rate Lowering Therapy in Acute Myocarditis

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 150 (estimated)
• Sponsor: Assiut University · Academic / Other
• Sex: All
• Age: 18 Years – 90 Years
• Healthy volunteers: Not accepted

Summary

To study the value of heart rate lowering therapy "pharmacological rest" on the short term in cases of myocarditis without LV dysfunction.

Conditions

• Myocarditis

Interventions

Type	Name	Description
DRUG	Ivabradine	heart rate lowering therapy

Timeline

• Start date: 2024-04-01
• Primary completion: 2025-04-01
• Completion: 2025-06-01
• First posted: 2024-03-15
• Last updated: 2024-03-15

Locations

1 site across 1 country: Egypt

Regulatory

• FDA-regulated drug study